Ratios in Focus: Analyzing QuidelOrtho Corporation (QDEL)’s Price-to-Cash and Price-to-Free Cash Flow

Abby Carey

In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.

In the latest session, QuidelOrtho Corporation (NASDAQ: QDEL) closed at $27.94 down -0.89% from its previous closing price of $28.19. In other words, the price has decreased by -$0.89 from its previous closing price. On the day, 1.0 million shares were traded. QDEL stock price reached its highest trading level at $28.63 during the session, while it also had its lowest trading level at $27.415.

Ratios:

For a deeper understanding of QuidelOrtho Corporation’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 12.51 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 145.93. For the most recent quarter (mrq), Quick Ratio is recorded 0.62 and its Current Ratio is at 1.12. In the meantime, Its Debt-to-Equity ratio is 1.00 whereas as Long-Term Debt/Eq ratio is at 0.80.

On May 08, 2025, Jefferies Upgraded its rating to Buy which previously was Hold but kept the price unchanged to $44.

Citigroup Upgraded its Neutral to Buy on December 11, 2024, whereas the target price for the stock was revised from $44 to $50.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 06 ’25 when The Bujarski 2007 Trust U/A Dt bought 100,200 shares for $47.50 per share.

Blaser Brian J. bought 6,033 shares of QDEL for $249,878 on Dec 11 ’24. The President and CEO now owns 6,033 shares after completing the transaction at $41.42 per share. On Dec 09 ’24, another insider, Robert Bujarski, who serves as the Former COO of the company, bought 20,000 shares for $40.40 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, QDEL now has a Market Capitalization of 1897138944 and an Enterprise Value of 4546338816. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.69 while its Price-to-Book (P/B) ratio in mrq is 0.68. Its current Enterprise Value per Revenue stands at 1.658 whereas that against EBITDA is 7.847.

Stock Price History:

The Beta on a monthly basis for QDEL is 0.35, which has changed by -0.26570302 over the last 52 weeks, in comparison to a change of 0.20772064 over the same period for the S&P500. Over the past 52 weeks, QDEL has reached a high of $49.45, while it has fallen to a 52-week low of $22.05. The 50-Day Moving Average of the stock is -1.66%, while the 200-Day Moving Average is calculated to be -11.46%.

Shares Statistics:

For the past three months, QDEL has traded an average of 1.30M shares per day and 1084070 over the past ten days. A total of 67.70M shares are outstanding, with a floating share count of 67.26M. Insiders hold about 0.94% of the company’s shares, while institutions hold 116.41% stake in the company. Shares short for QDEL as of 1760486400 were 8395606 with a Short Ratio of 6.44, compared to 1757894400 on 8152849. Therefore, it implies a Short% of Shares Outstanding of 8395606 and a Short% of Float of 20.54.

Earnings Estimates

At present, 6.0 analysts are actively evaluating the performance of QuidelOrtho Corporation (QDEL) in the stock market.The consensus estimate for the next quarter is $0.92, with high estimates of $1.04 and low estimates of $0.76.

Analysts are recommending an EPS of between $2.33 and $2.13 for the fiscal current year, implying an average EPS of $2.24. EPS for the following year is $2.99, with 6.0 analysts recommending between $3.19 and $2.67.

Revenue Estimates

A total of 6 analysts believe the company’s revenue will be $663.51M this quarter.It ranges from a high estimate of $671.6M to a low estimate of $658.34M. As of. The current estimate, QuidelOrtho Corporation’s year-ago sales were $727.1MFor the next quarter, 6 analysts are estimating revenue of $732.56M. There is a high estimate of $757.18M for the next quarter, whereas the lowest estimate is $719.7M.

A total of 7 analysts have provided revenue estimates for QDEL’s current fiscal year. The highest revenue estimate was $2.72B, while the lowest revenue estimate was $2.69B, resulting in an average revenue estimate of $2.7B. In the same quarter a year ago, actual revenue was $2.78BBased on 7 analysts’ estimates, the company’s revenue will be $2.78B in the next fiscal year. The high estimate is $2.82B and the low estimate is $2.74B.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.